For research use only. Not for therapeutic Use.
Toloxatone is an antidepressant launched in 1984 in France for the treatment of depression. It acts as a selective reversible inhibitor of MAO-A (RIMA).
| Catalog Number | I012017 |
| CAS Number | 29218-27-7 |
| Synonyms | Toloxatone, Humoryl; Delalande 69276. Perenum.;5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone |
| Molecular Formula | C11H13NO3 |
| Purity | ≥95% |
| Target | Monoamine Oxidase |
| Solubility | Soluble in DMSO |
| Storage | Store at 0-8 °C |
| IUPAC Name | 5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one |
| InChI | InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3 |
| InChIKey | MXUNKHLAEDCYJL-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC=C1)N2CC(OC2=O)CO |
| Reference | </br> 1: Provost JC, Funck-Brentano C, Rovei V, D/’Estanque J, Ego D, Jaillon P. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. Clin Pharmacol Ther. 1992 Oct;52(4):384-93. PubMed PMID: 1424410.</br> 2: Dingemanse J, Berlin I, Payan C, Thiede HM, Puech AJ. Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects. Psychopharmacology (Berl). 1992;106 Suppl:S68-70. PubMed PMID: 1546145.</br> 3: Giono-Barber H, Giono-Barber P, Milhaud CL, Klein MJ, Gouret C, Raynaud G. Effect of toloxatone on behaviour of primates. Arzneimittelforschung. 1977;27(6):1188-94. PubMed PMID: 409416.</br> 4: Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol. 1990 Dec;30(6):805-16. PubMed PMID: 1705137; PubMed Central PMCID: PMC1368300.</br> 5: Lemoine P, Mirabaud C. A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder. Psychopharmacology (Berl). 1992;106 Suppl:S118-9. PubMed PMID: 1546124.</br> 6: Vandel S, Bertschy G, Perault MC, Sandoz M, Bouquet S, Chakroun R, Guibert S, Vandel B. Minor and clinically non-significant interaction between toloxatone and amitriptyline. Eur J Clin Pharmacol. 1993;44(1):97-9. PubMed PMID: 8436164.</br> 7: Perna G, Cocchi S, Bertani A, Arancio C, Bellodi L. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study. J Clin Psychopharmacol. 1994 Dec;14(6):414-8. PubMed PMID: 7884022.</br> 8: Vistelle R, Lamiable D, Zinsou M, Leon A, Wiczewski M. Toloxatone pharmacokinetics in the plasma and cerebrospinal fluid of the rabbit. J Pharm Pharmacol. 1992 Feb;44(2):124-6. PubMed PMID: 1352813.</br> 9: Kaltenbach ML, Vistelle R, Hoizey G, Lamiable D, Zbierski L. Effect of acute ethanol administration on toloxatone pharmacokinetics in rabbits. Alcohol Clin Exp Res. 1999 May;23(5):885-90. PubMed PMID: 10371410.</br> 10: Vistelle R, Lamiable D, Zinzou M. Simple high-performance liquid chromatographic method for the measurement of toloxatone in rabbit cerebrospinal fluid and plasma. J Chromatogr. 1989 May 30;490(2):387-94. PubMed PMID: 2768411.</br> 11: Benedetti MS, Rovei V, Dencker SJ, Nagy A, Johansson R. Pharmacokinetics of toloxatone in man following intravenous and oral administrations. Arzneimittelforschung. 1982;32(3):276-80. PubMed PMID: 7200786.</br> 12: Vajta S, Le Moing JP, Rovei V. Gas–liquid chromatographic determination of toloxatone in human plasma. Routine analysis of a wide range of drug concentrations using a nitrogen-selective detector. J Chromatogr. 1983 May 13;274:139-48. PubMed PMID: 6874817.</br> 13: Mallesham B, Rajesh BM, Reddy PR, Srinivas D, Trehan S. Highly efficient CuI-catalyzed coupling of aryl bromides with oxazolidinones using Buchwald/’s protocol: a short route to linezolid and toloxatone. Org Lett. 2003 Apr 3;5(7):963-5. PubMed PMID: 12659549.</br> 14: Fernández Labriola R, Caetano Esquivel G, Alvarez M, Servidio M. [Toloxatone and depression]. Acta Psiquiatr Psicol Am Lat. 1991 Dec;37(4):291-8. Spanish. PubMed PMID: 1843597.</br> 15: Pateron D, Babany G, Hadengue A, Delafosse B, Degott C, Sylvain C, Larrey D, Benhamou JP. [Fatal fulminant hepatitis in 2 women taking toloxatone (Humoryl)]. Gastroenterol Clin Biol. 1990;14(5):504-6. French. PubMed PMID: 2365178.</br> 16: Cantagrel A, Dordain G, Dostert P. [Toloxatone, parkinsonism and dopa therapy]. Therapie. 1986 Nov-Dec;41(6):493-7. French. PubMed PMID: 3810545.</br> 17: Coston A, Gouret C, Raynaud G. Activity of toloxatone and various psychotropic drugs on the electrocorticogram and three limbic structures in the cat. Act Nerv Super (Praha). 1977 Jul;19 Suppl 2:331-3. PubMed PMID: 551645.</br> 18: Vajta S, Le Moing JP, Rovei V. Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolites. J Chromatogr. 1984 Nov 28;311(2):329-37. PubMed PMID: 6520180.</br> 19: Malnoë A, Benedetti MS. Metabolic fate of 3-(3-methylphenyl)-5-hydroxymethyl-2-oxazolidinone (toloxatone), a new antidepressant agent, in man. Xenobiotica. 1979 May;9(5):281-8. PubMed PMID: 494659.</br> 20: Lefebvre H, Richard R, Noblet C, Moore N, Wolf LM. Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine. Lancet. 1993 Feb 27;341(8844):555-6. PubMed PMID: 8094790.</br></br></br> |
